These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

932 related articles for article (PubMed ID: 16869901)

  • 1. Influence of probiotic vaginal lactobacilli on in vitro adhesion of urogenital pathogens to vaginal epithelial cells.
    Zárate G; Nader-Macias ME
    Lett Appl Microbiol; 2006 Aug; 43(2):174-80. PubMed ID: 16869901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adhesion of Lactobacillus vaginal strains with probiotic properties to vaginal epithelial cells.
    Ocaña V; Nader-Macías ME
    Biocell; 2001 Dec; 25(3):265-73. PubMed ID: 11813542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of the capacity of Lactobacillus to inhibit the growth of uropathogens and block their adhesion to vaginal epithelial cells.
    Osset J; Bartolomé RM; García E; Andreu A
    J Infect Dis; 2001 Feb; 183(3):485-91. PubMed ID: 11133381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lactobacillus inhibit adhesion of Staphylococcus aureus to HeLa cells].
    Wang J; Zhang R; Zhou L; Su X; Hu C; Zhu B; Feng T
    Sheng Wu Gong Cheng Xue Bao; 2012 Jun; 28(6):715-25. PubMed ID: 23016308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effect of vaginal Lactobacillus paracasei CRL 1289 against urogenital infection produced by Staphylococcus aureus in a mouse animal model.
    Zárate G; Santos V; Nader-Macias ME
    Infect Dis Obstet Gynecol; 2009; 2009():48358. PubMed ID: 17485818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro evaluation on HeLa cells of protective mechanisms of probiotic lactobacilli against Candida clinical isolates.
    Coman MM; Verdenelli MC; Cecchini C; Silvi S; Orpianesi C; Caspani M; Mondello F; Cresci A
    J Appl Microbiol; 2015 Nov; 119(5):1383-90. PubMed ID: 26335148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of some pharmaceutical excipients on the survival of probiotic vaginal lactobacilli.
    Zárate G; Tomás MS; Nader-Macias ME
    Can J Microbiol; 2005 Jun; 51(6):483-9. PubMed ID: 16121226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adherence of Lactobacillus plantarum P 17630 in soft-gel capsule formulation versus Döderlein's bacillus in tablet formulation to vaginal epithelial cells.
    Bonetti A; Morelli L; Campominosi E; Ganora E; Sforza F
    Minerva Ginecol; 2003 Jun; 55(3):279-84, 284-7. PubMed ID: 14581876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adhesion ability of Lactobacillus to vaginal epithelial cells: study by microbiological methods.
    Ocaña VS; Elena Nader-Macías M
    Methods Mol Biol; 2004; 268():441-5. PubMed ID: 15156055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaginal lactic acid bacteria in the mare: evaluation of the probiotic potential of native Lactobacillus spp. and Enterococcus spp. strains.
    Fraga M; Perelmuter K; Delucchi L; Cidade E; Zunino P
    Antonie Van Leeuwenhoek; 2008; 93(1-2):71-8. PubMed ID: 17588124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urogenital pathogen inhibition and compatibility between vaginal Lactobacillus strains to be considered as probiotic candidates.
    Juárez Tomás MS; Saralegui Duhart CI; De Gregorio PR; Vera Pingitore E; Nader-Macías ME
    Eur J Obstet Gynecol Reprod Biol; 2011 Dec; 159(2):399-406. PubMed ID: 21862199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of vaginal lactobacilli coaggregation ability with Escherichia coli.
    Ekmekci H; Aslim B; Ozturk S
    Microbiol Immunol; 2009 Feb; 53(2):59-65. PubMed ID: 19291088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of lactobacilli administration in the vaginal tract of mice: evaluation of side effects and local immune response by local administration of selected strains.
    Vintiñi E; Ocaña V; Elena Nader-Macías M
    Methods Mol Biol; 2004; 268():401-10. PubMed ID: 15156050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo effects of beneficial vaginal lactobacilli on pathogens responsible for urogenital tract infections.
    De Gregorio PR; Tomás MSJ; Terraf MCL; Nader-Macías MEF
    J Med Microbiol; 2014 May; 63(Pt 5):685-696. PubMed ID: 24523160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of Lactobacillus probiotics for bacterial genitourinary infections in women: a review.
    Barrons R; Tassone D
    Clin Ther; 2008 Mar; 30(3):453-68. PubMed ID: 18405785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Staphylococcus aureus by H2O2-producing Lactobacillus gasseri isolated from the vaginal tract of cattle.
    Otero MC; Nader-Macías ME
    Anim Reprod Sci; 2006 Nov; 96(1-2):35-46. PubMed ID: 16386389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lactobacilli in the female genital tract in relation to other genital microbes and vaginal pH.
    Rönnqvist PD; Forsgren-Brusk UB; Grahn-Håkansson EE
    Acta Obstet Gynecol Scand; 2006; 85(6):726-35. PubMed ID: 16752267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probiotic properties of vaginal lactic acid bacteria to prevent metritis in cattle.
    Otero MC; Morelli L; Nader-Macías ME
    Lett Appl Microbiol; 2006 Jul; 43(1):91-7. PubMed ID: 16834727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Putative Adhesion Factors in Vaginal Lactobacillus gasseri DSM 14869: Functional Characterization.
    Zeng Z; Zuo F; Marcotte H
    Appl Environ Microbiol; 2019 Oct; 85(19):. PubMed ID: 31420338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inhibitor effect of vaginal lactobacilli on group B streptococci].
    Açikgöz ZC; Gamberzade S; Göçer S; Ceylan P
    Mikrobiyol Bul; 2005 Jan; 39(1):17-23. PubMed ID: 15900833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.